Welcome to our dedicated page for Maxlinear SEC filings (Ticker: MXL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to MaxLinear, Inc. (Nasdaq: MXL) SEC filings, offering a structured view of the company’s regulatory disclosures as a U.S. public issuer. MaxLinear operates in the semiconductor and related device manufacturing industry, supplying RF, analog, digital and mixed-signal integrated circuits for connectivity, infrastructure, and industrial and multi-market applications.
Through its filings with the U.S. Securities and Exchange Commission, MaxLinear reports financial results, material events, and risk factors. Current reports on Form 8‑K have disclosed unaudited quarterly financial results, including net revenue, margins, operating expenses, and earnings measures, as well as the authorization of a share repurchase program that allows the company to buy back a specified amount of its common stock over a multi-year period. These 8‑K filings often incorporate related press releases by reference.
Investors can use this filings page to locate MaxLinear’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which typically contain detailed discussions of the company’s business, segment information, risk factors, management’s discussion and analysis, and notes to the financial statements. The risk factor sections elaborate on topics highlighted in press releases, such as competition in the semiconductor industry, market cyclicality, trade and tariff issues, geopolitical conditions, customer demand variability, legal proceedings, and technology and cybersecurity considerations.
In addition to periodic reports, users can review Forms 8‑K for announcements about financial results, share repurchase authorizations, and other significant events. Where applicable, insider transaction reports on Form 4 and proxy statements on Schedule 14A can provide further insight into executive and director share ownership, equity awards, and governance matters. Stock Titan’s interface is designed to surface these filings as they are made available through EDGAR and to pair them with AI-powered summaries that explain key points, highlight important changes, and help readers interpret complex sections of lengthy documents such as 10‑K and 10‑Q reports.
Form 4 — MaxLinear, Inc. (MXL): Steven G. Litchfield
The filing reports insider equity awards for Steven G. Litchfield (Chief Financial Officer and Chief Corporate Strategy Officer). On 07/27/2025 an outstanding option was amended: the "old" option (originally granted 08/10/2018, fully vested on 07/02/2022) was cancelled and a replacement option was granted. The replacement option covers 306,000 shares with an exercise price of $18.40, exercisable on 08/10/2025 and expiring 08/10/2028. Additionally, 77,760 Restricted Stock Units (RSUs) were granted on 08/04/2025, each representing one share, vesting one-third on 05/20/2026 and annually thereafter to full vesting on 05/20/2028. The form is signed by Connie Kwong as attorney-in-fact on 08/05/2025.